113 related articles for article (PubMed ID: 11817033)
1. Separation methods for acyclovir and related antiviral compounds.
Loregian A; Gatti R; Palù G; De Palo EF
J Chromatogr B Biomed Sci Appl; 2001 Nov; 764(1-2):289-311. PubMed ID: 11817033
[TBL] [Abstract][Full Text] [Related]
2. Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution.
Pham-Huy C; Stathoulopoulou F; Sandouk P; Scherrmann JM; Palombo S; Girre C
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(1):47-53. PubMed ID: 10517221
[TBL] [Abstract][Full Text] [Related]
3. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
4. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
5. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
6. Analysis of acyclovir by high performance capillary electrophoresis with on-column amperometric detection.
Zhang S; Yuan Z; Liu H; Zou H; Xiong H; Wu Y
Electrophoresis; 2000 Aug; 21(14):2995-8. PubMed ID: 11001315
[TBL] [Abstract][Full Text] [Related]
7. Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.
James SH; Prichard MN
Curr Opin Virol; 2014 Oct; 8():54-61. PubMed ID: 25036916
[TBL] [Abstract][Full Text] [Related]
8. Simple and rapid RP-HPLC method for simultaneous determination of acyclovir and zidovudine in human plasma.
Sharma M; Nautiyal P; Jain S; Jain D
J AOAC Int; 2010; 93(5):1462-7. PubMed ID: 21140658
[TBL] [Abstract][Full Text] [Related]
9. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor.
Schenkel F; Rudaz S; Daali Y; Oestreicher MK; Veuthey JL; Dayer P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):1-7. PubMed ID: 16140045
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.
Shakiba S; Freeman WR; Flores-Aguilar M; Munguia D; Tatebayashi M; Besen G; Amani R; Wiley CA; Vuong C; Aldern KA
Antimicrob Agents Chemother; 1995 Jun; 39(6):1383-5. PubMed ID: 7574537
[TBL] [Abstract][Full Text] [Related]
13. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.
Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA
Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156
[TBL] [Abstract][Full Text] [Related]
15. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
16. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
18. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
19. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antiviral activity of different origin compounds by flow cytometry.
Siennicka J; Trzcińska A; Kańtoch M
Acta Microbiol Pol; 2002; 51(1):79-83. PubMed ID: 12184452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
